Donald Trump’s Mexican Imports The businessman favors the importation of foreign-made drugs.

http://www.wsj.com/articles/donald-trumps-mexican-imports-1457481637

“Mr. Trump is a business nationalist without a core philosophy of government, so his policy arc is going to be an adventure. But some of his voters might be surprised to learn that he wants to flood the U.S. with cheap Mexican goods and other dangerous foreign imports.”

Donald Trump is going to build a wall, and it’s going to be a beautiful wall, and everyone will love it—but it’s also going to have one notable side entrance. To wit, the GOP frontrunner won’t let Mexicans into America but he’ll make an exception for Mexican drugs.

Mr. Trump released a 10-paragraph health plan last week, perhaps in response to the criticism that he has no policy details. We’ll discuss the complete outline at a later date, but one detail that leapt out for comment is his endorsement of foreign pharmaceutical importation—an idea even liberals left for dead a decade ago. His campaign promises to “remove barriers to entry into free markets,” because “allowing consumers access to imported, safe and dependable drugs from overseas will bring more options to consumers.”

Sorry, it won’t. The U.S. maintains a “closed” drug distribution network of manufacturers, suppliers and pharmacies—precisely because overseas drugs often aren’t safe and dependable. Recent years have seen a proliferation of pill mills and forgery rings that slip counterfeit or adulterated products into global supply chains. The World Health Organization estimates 10% of drugs world-wide are bogus.

In the case of Mexico, the U.S. State Department warns travellers that as many as 25% of the medications available south of the border are fake. The Los Zetas, Sinaloa and Juárez cartels have diversified their portfolios into deceptive pharmaceuticals. The modern “closed” U.S. system was created in 1999 because Southern California was awash with fraudulent black-market compounds smuggled from Mexico. CONTINUE AT SITE

 

 

Comments are closed.